Asia Pacific Biologics CMO Excellence Awards 2024
Recognizing Asia’s Best in Contract Manufacturing & Digitalisation in the Biologics Industry
Asia Pacific Biologics CMO Excellence Awards 2024
Asia Pacific Biologics CMO Excellence Awards 2024 seeks to give recognition to exceptional CMOs & CDMOs that facilitate biologics manufacturing excellence at enhanced speed, reduced cost, and superior quality from the biologics contract manufacturing space. Featuring top CMO / CDMO leaders in the industry, along with the latest advances in technologies and best practices in biologics R&D and manufacturing, the Asia Pacific Biologics CMO Excellence Awards 2024 applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow.
This year, we are thrilled to introduce a new dimension to our awards ceremony, as a part of Biologics Digitalisation & AI World 2024 highlighting the pivotal role of digitalization and artificial intelligence in revolutionizing the biologics landscape. This track will celebrate the trailblazing advancements that propel the industry forward into the era of digital transformation.
Important Event Information
Asia Pacific Biologics CMO Excellence Awards 2024
6:00 PM SGT
10th September 2024
Suntec Singapore Convention & Exhibition Centre
- Form valuable connections with established contract manufacturers and solution providers in the APAC region.
- Gain unique insights from Awards Winners in order to build your own company’s efforts in the biopharma space.
- Enjoy cocktails and dinner while networking in a relaxed atmosphere!
APBCEA 2024 Categories
- Best Biologics CMO Award: Bioprocessing
- Best Biologics CMO Award: Scale-Up
- Best Biologics CMO Award: Automation
- Best Biologics CMO Award: Fill-Finish
- Best Biologics CMO Award: Analytical Services
- Best Biologics CMO Award: Quality
- Best Biologics CMO in Southeast Asia
- Best Biologics CMO in Greater China Region
- Best Biologics CMO in Japan
- Best Biologics CMO in South Asia
- Best Biologics CMO in South Korea
- Best Biologics CMO in Australasia
- Best Biologics CMO in Asia Pacific
- Best CMO Startup of the Year
- Best CDMO Award of the Year
- Best Cell Therapy CMO in Asia Pacific
- Best Gene Therapy CMO in Asia Pacific
- Best mRNA CMO in Asia Pacific
- Best Biologics Digitalisation Award: Manufacturing Automation
- Best Biologics Digitalisation Award: Data Analytics for Quality Processes
- Best Biologics Digitalisation Award: Patient Centric Supply Chain
- Best Biologics Digitalisation Award: Preventive Maintenance
- Best Biologics Digitalisation Award: Drug Discovery
How does it work?
IMAPAC, the organizing committee of APBCEA 2024, will announce the call for nominations for the Asia Pacific Biologics CMO Excellence Awards. The nominations will be thoroughly reviewed and assessed.
Following a meticulous evaluation process, the top 5 entries in each category will be shortlisted. These entries will be selected based on their merit and suitability. The award winners will then be determined through voting results from the biopharma community.
TIMELINE OF AWARDS
Call for Nomination
Nominations Closed and Final nominees shortlisted for all award categories
Final nominees shortlisted for all award categories
Public Voting Open
Public Voting closed
Award winners notified
APBCEA 2024 Awards Ceremony
APBCEA 2024 Media Partner
BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. Som ensuring the information is always guaranteed to remain timely, informative, and unbiased.
AWARDS CRITERIA
The criteria for a company to be eligible for the Asia Pacific Biologics CMO Excellence Awards 2024 are:
- The company should be an organization that is involved in biopharmaceutical development and/or manufacturing.
- The company should have a notable presence in APAC.
- The company should have displayed significant developments in the past few years.
Based on the number of nominations and assessment, the top 5-7 entries under each category will be shortlisted. From the top 5-7 entries, the award winner will be determined by 100% voting results from the Biologics, Vaccine, and Cell & Gene Therapy Manufacturing community. Companies with the most number of votes will win the award in their respective category.
WHAT CAN YOU EXPECT?
CHOOSE YOUR PLAN
Select the Ticketing Option That Fits Your Needs
BOOK A TABLE
Our award can boost your company’s recognition and reputation, portraying innovation and adaptability. The awards give you the opportunity to showcase your technologies and get recognised for your achievements. We recognise and value outstanding achievements and technologies made by experts in the industry.
